Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14.4Revenue $M0.1Net Margin (%)-13,731.6Z-Score-14.5
Enterprise Value $M6.6EPS $-50.8Operating Margin %-11,085.7F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-13,730.6Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %0Quick Ratio10.1Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio10.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-239.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M4.5ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BIOC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BERG JEFFREY HDirector 2012-03-07Sell5,000$5.55-36.76 view
LoCastro MarcellaDirector 2011-12-16Buy1,500$4.49-21.83 view
LoCastro MarcellaDirector 2011-12-15Buy1,750$4.45-21.12 view
PARKER WALLACE P JRDirector 2011-12-07Buy1,000$4.25-17.41 view
PARKER WALLACE P JRDirector 2011-12-05Buy3,000$4.37-19.68 view
PARKER WALLACE P JRDirector 2011-11-22Buy1,000$4.4-20.23 view
PARKER WALLACE P JRDirector 2011-03-15Buy400$4.64-24.35 view
PARKER WALLACE P JRDirector 2011-03-14Buy1,600$4.64-24.35 view
PARKER WALLACE P JRDirector 2011-03-10Buy1,200$4.64-24.35 view
PARKER WALLACE P JRDirector 2011-03-01Buy2,000$4.97-29.38 view

Press Releases about BIOC :

    Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Sep 19 2014
    Biocept Granted Patent in China for Its Microfluidic Channel Technology Used to Capture Circulating... Sep 18 2014
    Biocept to Present at Upcoming Investor Conferences Sep 04 2014
    Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe Sep 03 2014
    BIOCEPT INC Financials Aug 19 2014
    Biocept Provides Second Quarter Operational Update Aug 14 2014
    BIOCEPT INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy Aug 06 2014
    BIOCEPT INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 24 2014
    Exclusive: Biocept's CEO Lays Out This Small Cap's Massive Opportunity Jul 08 2014
    BIOCEPT INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 18 2014
    5 Stocks Poised for Breakouts Jun 13 2014
    BIOCEPT INC Files SEC form 8-K, Change in Directors or Principal Officers May 23 2014
    BIOCEPT INC Files SEC form 10-Q, Quarterly Report May 14 2014
    BIOCEPT INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... May 06 2014
    BIOCEPT INC Files SEC form 10-K, Annual Report Mar 28 2014
    Biocept Appoints Commercialization Leader to Implement Global Diagnostic Sales Program Mar 24 2014
    BIOCEPT INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 17 2014
    Health-care IT firm Castlight soars 139% after IPO Mar 14 2014
    Biocept, Inc. to Present at the 26th Annual ROTH Conference Mar 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK